SRZN 10.56 (+6.99%)
US86889P1093BiotechnologyBiotechnology

Surrozen (SRZN) Stock Highlights

10.56 | +6.99%
2024-12-21 07:25:36
Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

Statistics

Range Today
9.69 10.71
Volume Today 24.4K
Range 1 Year
6 16.19
Volume 1 Year 4.6M
Range 3 Year
4.5 116.63
Volume 3 Year 11.75M
Range 10 Year
4.5 210
Volume 10 Year 13.23M

Highlights

Market Capitalization 32.67M (micro)
Floating Shares 1.12M
Current Price 10.56
Price To Earnings -0.6
Price To Book 0.55
Earnings Per Share -16.92
Payout Ratio 0%

Performance

Latest +6.99%
1 Month +12.34%
3 Months +30.86%
6 Months +1.54%
1 Year +31.18%
3 Years -89.55%
5 Years -92.96%
10 Years -92.96%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.